STOCK TITAN

InspireMD to Present at Upcoming H.C. Wainwright 27th Annual Global Investment Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

InspireMD (NASDAQ:NSPR), the developer of the CGuard® Prime carotid stent system for stroke prevention, will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10th at 10:00am ET.

Investors can access both the live audio webcast and replay of the presentation through the company's website investor calendar section at inspiremd.com/investors/investor-calendar/.

InspireMD (NASDAQ:NSPR), sviluppatore del sistema di stent carotideo CGuard® Prime per la prevenzione dell'ictus, presenterà al H.C. Wainwright 27th Annual Global Investment Conference il 10 settembre alle 10:00 ET.

Gli investitori possono seguire sia la diretta audio webcast sia la registrazione della presentazione nella sezione calendario investitori del sito web della società all'indirizzo inspiremd.com/investors/investor-calendar/.

InspireMD (NASDAQ:NSPR), desarrollador del sistema de stent carotídeo CGuard® Prime para la prevención del ictus, presentará en la H.C. Wainwright 27th Annual Global Investment Conference el 10 de septiembre a las 10:00 ET.

Los inversores podrán acceder tanto a la retransmisión de audio en directo como a la grabación de la presentación a través de la sección calendario de inversores en la página web de la compañía: inspiremd.com/investors/investor-calendar/.

InspireMD (NASDAQ:NSPR)는 뇌졸중 예방용 카로티드 스텐트 시스템 CGuard® Prime의 개발사로서 H.C. Wainwright 27th Annual Global Investment Conference에서 현지시간 9월 10일 오전 10:00(ET)에 발표할 예정입니다.

투자자들은 회사 웹사이트의 투자자 캘린더 섹션 inspiremd.com/investors/investor-calendar/를 통해 발표의 실시간 오디오 웹캐스트와 재생 영상을 모두 이용할 수 있습니다.

InspireMD (NASDAQ:NSPR), développeur du système de stent carotidien CGuard® Prime pour la prévention des AVC, présentera lors de la H.C. Wainwright 27th Annual Global Investment Conference le 10 septembre à 10h00 ET.

Les investisseurs peuvent accéder au webcast audio en direct ainsi qu'à la rediffusion de la présentation via la section calendrier investisseurs du site web de la société : inspiremd.com/investors/investor-calendar/.

InspireMD (NASDAQ:NSPR), Entwickler des Carotis-Stent-Systems CGuard® Prime zur Schlaganfallprävention, wird auf der H.C. Wainwright 27th Annual Global Investment Conference am 10. September um 10:00 Uhr ET präsentieren.

Investoren können sowohl das Live-Audio-Webcast als auch die Wiederholung der Präsentation über den Investor-Kalender auf der Unternehmenswebseite unter inspiremd.com/investors/investor-calendar/ abrufen.

Positive
  • None.
Negative
  • None.

MIAMI, Aug. 27, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to present at the upcoming H.C. Wainwright 27th Annual Global Investment Conference on Wednesday, September 10th at 10:00am Eastern Time (ET).

A live audio webcast and replay of the presentation may be accessed on the “Investor Calendar” section of the company’s website at: https://inspiremd.com/investors/investor-calendar/

About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.

Investor Contacts:
Webb Campbell
Gilmartin Group LLC
webb@gilmartinir.com
investor-relations@inspiremd.com


FAQ

When is InspireMD (NSPR) presenting at the H.C. Wainwright Conference?

InspireMD will present at the conference on Wednesday, September 10th, 2025 at 10:00am Eastern Time (ET).

How can investors access InspireMD's H.C. Wainwright conference presentation?

Investors can access both the live audio webcast and replay through the 'Investor Calendar' section on InspireMD's website at inspiremd.com/investors/investor-calendar/.

What is InspireMD's (NSPR) main product?

InspireMD's main product is the CGuard® Prime carotid stent system, which is designed for the prevention of stroke.

What stock exchange is InspireMD (NSPR) listed on?

InspireMD (NSPR) is listed on the NASDAQ stock exchange.
Inspiremd

NASDAQ:NSPR

NSPR Rankings

NSPR Latest News

NSPR Latest SEC Filings

NSPR Stock Data

100.13M
30.22M
18.19%
32.86%
0.95%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MIAMI